PMA device
Visx Star Excimer Laser System
Amo Manufacturing USA, LLC · Excimer Laser System (LZS, Class III) · First FDA decision Apr 27, 2001, newest Nov 6, 2001Nearsightedness and refractive error
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
PMA pathway
Device trials
1
Naming "Visx Star"
MAUDE reports
6
Brand "Visx Star", since 2015
PubMed studies
132
Mentioning "Visx Star"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Visx Star Excimer Laser System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- VISX STAR EXCIMER LASER SYSTEMPMA supplement
P930016-S014 · Decided Nov 6, 2001 · 155 days after receipt · Panel Track
Device type: Excimer laser system (LZS) · Ophthalmology
- VISX STAR EXCIMER LASER SYSTEMPMA supplement
P930016-S012 · Decided Apr 27, 2001 · 287 days after receipt · Panel Track
Device type: Excimer laser system (LZS) · Ophthalmology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Visx Star", any status and sponsor, newest update first.
- LASIK Using Contoura With Phorcides vs. iDesignActive, not recruiting
59th Medical WingFederal agency
NCT07128316 · 63 participants (planned) · Start Sep 11, 2023 · Primary completion Dec 15, 2025
Device: Contoura Topolyzer with Phorcides; iDesign · For: Myopia; Astigmatism
Sites: San Antonio, Texas
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Visx Star", and for the whole product code for context.
This brand
6 reports: 0 malfunction, 6 injury, 0 death
Whole product code LZS
7,603 reports: 949 malfunction, 6,624 injury, 12 death
Newest reports for this brand
JOHNSON & JOHNSON/ AMO MANUFACTURING USA, LLC.
MW5173062 · Received Jul 22, 2025 · Event dated Nov 30, 2022
Device type: Excimer Laser System (LZS)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Corneal Abrasion; Dry Eye(s); Fatigue; Itching Sensation; Pain; Burning Sensation; Neuralgia
AMO MANUFACTURING USA, LLC/JOHNSON & JOHNSON SURGICAL VISION, INC.
MW5166144 · Received Feb 13, 2025 · Event dated Feb 1, 2003
Device type: Excimer Laser System (LZS)
Patient problem as coded: Dry Eye(s); Vitreous Floaters; Visual Impairment; Halo; Diplopia/Double Vision
- VISX STAR S4Injury
JOHNSON AND JOHNSON SURGICAL VISION, INC. / ABBOTT MEDICAL OPTICS (AMO)
MW5109171 · Received Apr 20, 2022 · Event dated Jan 27, 2022
Device type: Excimer Laser System (LZS)
Device problem as coded: Patient-Device Incompatibility
Patient problem as coded: Emotional Changes; Blurred Vision; Visual Impairment; Visual Disturbances; Depression; Suicidal Ideation
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0443-2022 · Started Oct 21, 2021
Reason given: Aberrometer and precision laser systems are affected by a remote code execution vulnerability existing when the Microsoft Windows Print Spooler service is enabled, and improperly performs privileged file operations. This could be exploited to run arbitrary code with SYSTEM privileges, allowing for program...
Cause as FDA categorized it: Software design · Device type: Excimer Laser System (LZS)
VISX INCORPORATED, A SUBSIDIARY OF AMO INC
Z-1139-2008 · Started Dec 13, 2007 · Posted by FDA Jun 5, 2008
Reason given: Firm received two complaints (including one injury complaint) associated with the movement of the VISX chair while in the patient loading ("fully swung out" unlocked) position under an IntraLase FS laser.
Cause as FDA categorized it: Component design/selection · Device type: Excimer Laser System (LZS)
Published research
The most relevant PubMed records for "Visx Star"[tiab]. The summary above synthesizes these.
- Hyperopic laser-assisted in situ keratomileusis results with LADARVision, Visx Star S2, and Visx Star S3.
Oral D, Bowman RW, Cavanagh HD, et al. · Eye Contact Lens · 2004Comparative Study, Research Support, Non-U.S. Gov't
- Improved safety in contemporary LASIK.
Watson SL, Bunce C, Allan BD · Ophthalmology · 2005Comparative Study, Research Support, Non-U.S. Gov't
- Results of photorefractive keratectomy for hyperopia using the VISX star excimer laser system.
Stevens JD, Ficker LA · J Refract Surg · 2002Research Support, Non-U.S. Gov't
- Seven-year follow-up of LASIK for myopia.
Zalentein WN, Tervo TM, Holopainen JM · J Refract Surg · 2009Research Support, Non-U.S. Gov't
- Topography/wavefront-guided photorefractive keratectomy combined with crosslinking for the treatment of keratoconus: preliminary results.
Russo A, Faria-Correia F, Rechichi M, et al. · J Cataract Refract Surg · 2021
- Laser in situ keratomileusis with the VISX Star laser for myopia over -10.0 diopters.
Lyle WA, Jin GJ · J Cataract Refract Surg · 2001Clinical Trial
- Wavefront-guided versus wavefront-optimized photorefractive keratectomy: Clinical outcomes and patient satisfaction.
Sia RK, Ryan DS, Stutzman RD, et al. · J Cataract Refract Surg · 2015Comparative Study, Randomized Controlled Trial
- Human corneal ablation threshold using the 193-nm ArF excimer laser.
Berns MW, Chao L, Giebel AW, et al. · Invest Ophthalmol Vis Sci · 1999Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.
- Comparison of efficacy, safety, and predictability of laser in situ keratomileusis using two laser suites.
Meidani A, Tzavara C · Clin Ophthalmol · 2016
- The Effect of Flap Elevation on the Ocular Cyclotorsion in Customized Laser Ablation.
Kapelushnik N, Barequet D, Hirsh A, et al. · J Clin Med · 2025
- Scattered UV irradiation during VISX excimer laser keratorefractive surgery.
Hope RJ, Weber ED, Bower KS, et al. · Lasers Surg Med · 2008
- Long-term efficacy of phototherapeutic keratectomy on recurrent corneal erosion syndrome.
Baryla J, Pan YI, Hodge WG · Cornea · 2006
Other devices of this type
Also filed under product code LZS.
- WaveLight EX500 LaserAlcon Laboratories, Inc. · PMA 2025
- Wavelight Allegretto Wave Excimer Laser SystemAlcon Laboratories, Inc. · PMA 2013
- STAR S4 IR Excimer Laser System and iDESIGN Refractive StudioAmo Manufacturing USA, LLC · PMA 2019
- Nidek EC-5000 Excimer Laser SystemNidek Co., Ltd. · PMA 2018
- Bausch & Lomb Technolas T217Z Zyoptix Laser SystemTechnolas Perfect Vision GmbH · PMA 2010
- Ladarvision 4000 Excimer Laser System and the Ladar 6000 Excimer Laser SystemAlcon Laboratories · PMA 2006
- Allegretto Wave Eye-Q Excimer Laser SystemAlcon Laboratories, Inc. · PMA 2015
- Technolas 217A Excimer Laser SystemTechnolas Perfect Vision GmbH · PMA 2003
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.